CMPS Insider Trading

Insider Ownership Percentage: 4.25%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $16,376,463.02

COMPASS Pathways Insider Trading History Chart

This chart shows the insider buying and selling history at COMPASS Pathways by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$10M$0$10MTotal Insider BuyingTotal Insider Selling

COMPASS Pathways Share Price & Price History

Current Price: $2.83
Price Change: Price Decrease of -0.26 (-8.41%)
As of 04/3/2025 05:00 PM ET

This chart shows the closing price history over time for CMPS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$2.83Closing price on 04/03/25:

SEC Filings (Institutional Ownership Changes) for COMPASS Pathways (NASDAQ:CMPS)

46.19% of COMPASS Pathways stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CMPS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$26Mbought$4.82MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20M-$10M$0$10M$20MTotal InflowsTotal Outflows
COMPASS Pathways logo
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Read More on COMPASS Pathways

Today's Range

Now: $2.83
Low: $2.82
High: $2.99

50 Day Range

MA: $3.80
Low: $2.79
High: $4.99

52 Week Range

Now: $2.83
Low: $2.69
High: $10.31

Volume

779,244 shs

Average Volume

755,640 shs

Market Capitalization

$262.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.29

Who are the company insiders with the largest holdings of COMPASS Pathways?

COMPASS Pathways' top insider shareholders include:
  1. Life Sciences NV Atai (Major Shareholder)
  2. Ekaterina Malievskaia (Director)
  3. George Jay Goldsmith (Director)
  4. Ekaterina Malievskaia (Major Shareholder)
  5. George Jay Goldsmith (Major Shareholder)
Learn More about top insider investors at COMPASS Pathways.